Ligand validation:3ABW

L3P: 2,3-DI-O-PHYTANLY-3-SN-GLYCERO-1-PHOSPHORYL-3'-SN-GLYCEROL-1'-PHOSPHATE

L3P is a Ligand Of Interest in 3ABW designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
3ABW_L3P_D_314	0%	24%	0.583	0.602	1.92	1.2	8	2	4	0	34%	0.339
3ABW_L3P_A_313	0%	26%	0.559	0.505	1.93	1.11	8	1	1	0	34%	0.339
3ABW_L3P_B_311	0%	25%	0.708	0.641	1.93	1.14	8	2	2	0	34%	0.339
3ABW_L3P_D_312	0%	24%	0.632	0.556	1.94	1.22	8	2	0	0	34%	0.339
3ABW_L3P_A_317	0%	21%	0.62	0.525	1.97	1.35	8	2	2	0	34%	0.339
3ABW_L3P_A_310	0%	21%	0.593	0.445	1.98	1.37	8	3	0	0	34%	0.339
3ABW_L3P_B_315	0%	25%	0.71	0.494	1.92	1.14	8	2	1	0	34%	0.339
3ABW_L3P_B_318	0%	22%	0.656	0.391	1.96	1.31	8	2	1	0	34%	0.339
3ABW_L3P_D_316	0%	21%	0.664	0.267	2	1.32	8	2	1	0	34%	0.339
5B0W_L3P_B_302	2%	20%	0.287	0.662	1.93	1.44	8	4	1	0	34%	0.339
3VVK_L3P_D_302	1%	22%	0.331	0.669	2.05	1.19	9	3	0	0	34%	0.339
3A7K_L3P_A_333	0%	24%	0.423	0.561	1.93	1.18	8	1	1	0	34%	0.339
5ETZ_L3P_D_302	0%	25%	0.615	0.599	1.91	1.16	8	2	7	0	34%	0.339
1UCQ_L3P_A_260	2%	37%	0.419	0.694	1.25	1.24	8	7	3	0	100%	0.8898
1X0K_L3P_1_260	2%	31%	0.435	0.713	1.28	1.45	6	9	6	0	85%	0.8136
1X0S_L3P_A_260	1%	35%	0.472	0.628	1.26	1.29	8	7	4	0	100%	0.8898
3WQJ_L3P_A_305	1%	85%	0.259	0.524	0.24	0.5	-	-	0	0	34%	0.339

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.